Emily Drabrant Conley

Dr. Emily Drabant Conley is Chief Executive Officer of Federation Bio. Previously, Dr. Conley spent over a decade at 23andMe, where she helped scale the company from 30 employees into the world’s leading platform for genetic-driven drug discovery. As Vice President of Business Development at 23andMe, she architected visionary partnerships across pharma and biotech. ​Dr. Conley currently serves on the boards of Federation Bio, TMRW and Medrio and formerly served on the boards of Lesbians Who Tech and the UCSF Alliance Health Project.

In 2019, Dr. Conley was named one of Business Insider’s 30 Leaders Under 40 who are transforming U.S. healthcare and in 2020 she was honored by Google Ventures as one of the 25 women shaping the future of technology.

Dr. Conley spent 10 years in academia conducting genetics research. She was a research fellow at the National Institutes of Health and is co-author on more than 35 academic publications. She received her Ph.D. in Neuroscience from Stanford University School of Medicine, where she held fellowships from the National Science Foundation and Department of Defense. She graduated summa cum laude from Vanderbilt University with a B.A.